Why Korea Is Now More Attractive To U.S. Biopharma
Source: Life Science Leader
By Sungho Han, Ph.D.
By most measures, South Korea is an attractive market for pharma companies. The population, around 51 million, is roughly equal to California and North Carolina combined. Healthcare spending per capita is rising. Seniors — who account for higher pharmaceutical spending than other demographics — make up more than 16% of the population. Ranked by total spending, South Korea is among the top 15 markets for pharmaceutical sales.
VIEW THE MAGAZINE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader X
Subscribe to Life Science Leader